Abstract:Objective:Hepatocellular carcinoma (HCC) is a prevalent malignancy with poor survival. Different cell types in the tumor microenvironment participate in the tumorigenesis and progression of HCC. This study aimed to analyze the immune microenvironment of HCC and its relationship with clinical outcomes. Methods:We analyzed HCC RNA-seq for cell type identification and prognosis by estimating relative subsets of RNA transcripts using CIBERSORTx. The interaction between B cells and macrophages in HCC was analyzed using a Hepa1-6 orthotopic transplantation mouse model and flow cytometry. The effect of Zinc finger protein 296 (ZNF296) on the interaction of B cells and macrophages was verified using human HCC tissues analyzed through western blot, quantitative real-time polymerase chain reaction (qPCR), and multiplex immunofluorescence. A comparative analysis of immune cells associated with HCC prognosis was performed using RNA-seq data from The Cancer Genome Atlas (TCGA), bulk multimodal data, and single-cell transcriptomic data from existing HCC single-cell transcriptomic data employing the Single Cell Inferred Site Specific Omics Resource for Tumor Microenvironments (SCISSOR). Results:Liver hepatocellular carcinoma (LIHC) RNA-seq analysis of TCGA showed that high eosinophil infiltration promoted HCC progression. The proportion of B cells correlated with that of macrophages (r=-0.24) and affected the infiltration and programmed death ligand 1 (PD-L1) expression of macrophages in HCC. ZNF296 may participate in the interaction between B cells and macrophages to accelerate the HCC progression by regulating PAFAH1B3 and H2AFX. Moreover, ZNF296 expression positively correlated with LAG3 (r=0.27) and CTLA4 (r=0.31) expression levels. Among the immune cell phenotypes related to survival and death identified by SCISSOR analysis, T cells correlated with an excellent prognosis of HCC. The normal function of liver and dendritic cells was also associated with a good prognosis in HCC. Conclusions:This study analyzed the interaction of the immune microenvironment with HCC prognosis, identifying ZNF296 as a promising diagnostic and therapeutic target for HCC.

Interaction of KLF6 and Sp1 regulates basigin-2 expression mediated proliferation, invasion and metastasis in hepatocellular carcinoma

Zinc Finger Protein 296 Promotes Hepatocellular Carcinoma Progression Via Intervening Interaction Between Macrophages and B Cells.

Kruppel-Like Factor 6 Suppresses Growth and Invasion of Hepatocellular Carcinoma Cells in Vitro and in Vivo

A Negative Feedback Loop Between KLF9 and the EMT Program Dictates Metastasis of Hepatocellular Carcinoma.

Effect of KLF6 and Its Splice Variant KLF6V on Proliferation and Differentiation of Human Hepatocellular Carcinoma HepG2 Cells

Characterization of basigin isoforms and the inhibitory function of basigin-3 in human hepatocellular carcinoma proliferation and invasion

Inactivation of the Tumor Suppressor Krüppel-like Factor 6 (KLF6) by Mutation or Decreased Expression in Hepatocellular Carcinomas

Klf4-Mediated Cdh3 Upregulation Suppresses Human Hepatoma Cell Growth And Migration Via Gsk-3 Beta Signaling

Up-regulation of Krüppel-like Factor 8 Promotes Tumor Invasion and Indicates Poor Prognosis for Hepatocellular Carcinoma.

Krüppel-Like Factor 6 Downregulation Is Connected with a Poor Prognosis and Tumor Growth in Non-Small-Cell Lung Cancer

KLF4-mediated upregulation of CD9 and CD81 suppresses hepatocellular carcinoma development via JNK signaling

Under-expression of LKB1 is Associated with Enhanced P38-Mapk Signaling in Human Hepatocellular Carcinoma.

HMGB1-mediated elevation of KLF7 facilitates hepatocellular carcinoma progression and metastasis through upregulating TLR4 and PTK2

Transcription Factor Specificity Protein 1-Mediated Serine/threonine Kinase 39 Upregulation Promotes the Proliferation, Migration, Invasion and Epithelial–mesenchymal Transition of Hepatocellular Carcinoma Cells by Activating the Transforming Growth Factor-Β1 /smad2/3 Pathway

BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis.

Suppression of Lung Cancer Cell Invasion by LKB1 is Due to the Downregulation of Tissue Factor and Vascular Endothelial Growth Factor, Partly Dependent on SP1

Comprehensive Analysis of KLF2 As a Prognostic Biomarker Associated with Fibrosis and Immune Infiltration in Advanced Hepatocellular Carcinoma.

Dysregulated Krüppel-like Factor 4 and Vitamin D Receptor Signaling Contribute to Progression of Hepatocellular Carcinoma.

Suppression of Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells by Krüppel-like Factor 4.

Klf4 Inhibits Tumor Growth and Metastasis by Targeting Microrna-31 in Human Hepatocellular Carcinoma

Mutations of the Tumor Suppressor Kruppel-like Factor 6 (KLF6) Gene in Hepatocellular Carcinoma and Its Effect of Growth Suppression on Human Hepatocellular Carcinoma Cell Line HepG2